Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) ROCE % : 0.00% (As of Mar. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Caliber Imaging & Diagnostics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Caliber Imaging & Diagnostics's annualized ROCE % for the quarter that ended in Mar. 2014 was 0.00%.

Caliber Imaging & Diagnostics ROCE % Historical Data

The historical data trend for Caliber Imaging & Diagnostics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliber Imaging & Diagnostics ROCE % Chart

Caliber Imaging & Diagnostics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

ROCE %

Caliber Imaging & Diagnostics Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14
ROCE %	Get a 7-Day Free Trial													-	-2,340.11	-410.46	-	-

Caliber Imaging & Diagnostics ROCE % Calculation

Caliber Imaging & Diagnostics's annualized ROCE % for the fiscal year that ended in Dec. 2013 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2013 )		(A: Dec. 2012 )		(A: Dec. 2013 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2013 )		(A: Dec. 2012 )		(A: Dec. 2013 )
	=	-4.718	/	( ( (2.591 - 3.094)	+	(2.408 - 7.411) )	/ 2 )
	=	-4.718	/	( (-0.503	+	-5.003)	/ 2 )
	=	-4.718	/	-2.753
	=	171.38 %

Caliber Imaging & Diagnostics's ROCE % of for the quarter that ended in Mar. 2014 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2014 )		(Q: Dec. 2013 )		(Q: Mar. 2014 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2014 )		(Q: Dec. 2013 )		(Q: Mar. 2014 )
	=	-6.424	/	( ( (2.408 - 7.411)	+	(2.213 - 8.776) )	/ 2 )
	=	-6.424	/	( ( -5.003	+	-6.563 )	/ 2 )
	=	-6.424	/	-5.783
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2014) EBIT data.

Caliber Imaging & Diagnostics (OTCPK:LCDX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Caliber Imaging & Diagnostics ROCE % Related Terms

Thank you for viewing the detailed overview of Caliber Imaging & Diagnostics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Caliber Imaging & Diagnostics Inc (OTCPK:LCDX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Burtt Road, Suite 203, Andover, MA, USA, 01810

Website

http://www.caliberid.com

Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.

Executives

Paul Stuka	director	C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109
William J Shea	director, 10 percent owner	11825 N PENNSYLVANIA ST, CARMEL IN 46032
Kevin M Cronin	director
Richard Christopher	officer: Chief Financial Officer	C/O LUCID, INC., 50 METHODIST HILL DR, SUITE 1000, ROCHESTER NY 14623
Martin Joseph Joyce	officer: Chief Financial Officer	1050 HINGHAM STREET, ROCKLAND MA 02370
Matthew S Cox	director	58 OAKWOOD DRIVE, CHAPEL HILL NC 27517

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Headlines

From GuruFocus

Caliber Imaging & Diagnostics, Formerly Lucid, Inc. (LCDX), Has No Relation To Lucid Motors

By PRNewswire PRNewswire • 08-25-2020